Lichen Sclerosus
Authors:
- Gary VentoliniGVGary Ventolini
- Krista M. SwensonKSKrista M. Swenson
- Michael L. GallowayMGMichael L. Galloway
- 1 July 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 16 (3) , 271-274
Abstract
The purpose of our study was to compare clinical data regarding patients with pruritic lichen sclerosus (LS) at moderate or severe stages using 2 different therapies with a 5-year follow-up. The study was approved by the institutional review board and was presented as a retrospective clinical data review of patients with pruritic biopsy diagnosis LS who underwent therapy at our university private practice from 2002 to 2005. We compared the results of a weekly topical application of high-potency steroid (HPS) with a combined HPS and monthly anesthetic/steroid subdermal injection (ASI). Outcomes were timed to achieve pruritus-free status, the number of symptomatic recurrences, and patient satisfaction with therapy. Fifty-four patients were diagnosed with LS between 2002 and 2005. There were 13 patients who had mild-stage, 25 who had moderate-stage, and 16 who had severe-stage LS. Five-year follow-up data on 17 patients with moderate-stage LS and 14 patients with severe-stage LS were obtained. Time to pruritus free was 6 weeks with ASI and 19 weeks with HPS for moderate-stage LS (p = .04) and 9 weeks with ASI and 24 weeks with HPS for severe-stage LS (p = .03). Recurrences were more frequent on HPS for moderate-stage LS (p = .04) but not significant with HPS for severe-stage LS (p = .15). Only ASI was successful at treating patients with recalcitrant pruritus. In our population, patients with symptomatic moderate-stage LS seem to have a more rapid and prolonged response to ASI than to HPS but are less satisfied with the injections.Keywords
This publication has 11 references indexed in Scilit:
- A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosusJournal of the American Academy of Dermatology, 2011
- Lichen SclerosusDermatologic Clinics, 2010
- Lichen Sclerosus: Subdermal Steroid Injection Therapy. A Large, Long-Term Follow-Up StudyJournal of Gynecologic Surgery, 2006
- The Outcome after Cryosurgery and Intralesional Steroid Injection in Vulvar Lichen sclerosus Corresponds to Preoperative Histopathological FindingsDermatology, 2005
- Lichen sclerosus vulvaeDie Dermatologie, 2004
- Management of Autoimmune Skin Disorders in the ElderlyDrugs & Aging, 2004
- Vulvar Lichen SclerosusAmerican Journal of Clinical Dermatology, 2004
- Vulvar squamous cell carcinoma and lichen sclerosusAustralasian Journal of Dermatology, 1997
- Subdermal Decadron and Bupivacaine to Treat Symptomatic Lichen SclerosusJournal of Gynecologic Surgery, 1995
- Lichen sclerosus et atrophicus.BMJ, 1987